ProCE Banner Activity

Expert Insight on Important Clinical Trial Data From ESGO 2021 Informing Treatment for Ovarian Cancer and Endometrial Cancers

Conference Coverage
Podcast Episodes
In this podcast episode, listen to Nicole Concin, MD, PhD, as she highlights important clinical trial data for ovarian and endometrial cancers presented at the ESGO 2021 annual meeting.

Released: November 23, 2021

Expiration: November 22, 2022

No longer available for credit.

Share

Faculty

Nicole Concin

Nicole Concin, MD, PhD

Professor
Department of Gynaecology and Obstetrics
Medical University Innsbruck
Innsbruck, Austria
Consultant in Gynaecological Oncology
Department of Gynaecology and Gynaecologocial Oncology
KEM Evang. Kliniken Essen-Mitte
Essen, Germany

Supporters

This educational activity is supported by an educational grant from

GlaxoSmithKline

Faculty Disclosure

Primary Author

Nicole Concin, MD, PhD

Professor
Department of Gynaecology and Obstetrics
Medical University Innsbruck
Innsbruck, Austria
Consultant in Gynaecological Oncology
Department of Gynaecology and Gynaecologocial Oncology
KEM Evang. Kliniken Essen-Mitte
Essen, Germany

Nicole Concin, MD, PhD, has disclosed that she has received consulting fees from Akesobio, AstraZeneca, Ensai, eTheRNA immunotherapies NV, GlaxoSmithKline, Mersana, and Seattle Genetics and other financial or material support from Amgen, Genmab, MSD, and Roche.